In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.
Ocaña A, Pérez-Peña J, Alcaraz-Sanabria A, Sánchez-Corrales V, Nieto-Jiménez C, Templeton AJ, Seruga B, Pandiella A, Amir E.
Ocaña A, et al.
Oncotarget. 2016 Apr 19;7(16):22865-72. doi: 10.18632/oncotarget.8118.
Oncotarget. 2016.
PMID: 26992217
Free PMC article.
Expression of 9 of these genes (CDC28, CHK1, NIMA, Aurora kinase A, Aurora kinase B, BUB1, BUB1betaB, CDKN2A and TTK) was associated with worse PFS (HR:3.40, log rank p<0.001). ...
Expression of 9 of these genes (CDC28, CHK1, NIMA, Aurora kinase A, Aurora kinase B, BUB1, BUB1betaB, CDKN2A and TTK) was associated …